Anti-CD19 antibody [EPR23174-145]

35 product images

• 

  Flow Cytometry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Flow cytometric analysis of mouse peripheral blood mononuclear cell (PBMC) cells labeling CD19 with ab245235 at 1/500 dilution (Right) compared with a Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) isotype control (Left). Goat anti rabbit IgG (Alexa Fluor^® 488, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077) at 1/2000 dilution was used as the secondary antibody.
  

  Cells were stained with rabbit IgG (Left) or ab245235 (Right). Then stained with anti-CD3 conjugated to Alexa Fluor^® 647. CD19 and CD3 are mutually exclusive expressed in mouse PBMC.

  Gated on viable cells.

• 

  Immunohistochemistry (Frozen sections) - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Immunohistochemical analysis of 4% PFA-fixed, 0.2% Triton X-100 permeabilized perfusion fixed frozen Mouse spleen tissue labeling CD19 with ab245235 at 1/250 (1.82 ug/ml) dilution followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) at 1/1000 dilution (Green). Positive staining on mouse spleen. is observed. The nuclear counterstain was DAPI (Blue).
  

  Secondary antibody control: Secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) at 1000 dilution.

  Heat mediated antigen retrieval using sodium citrate buffer (10mM citrate pH 6.0 + 0.05% Tween-20).

• 

  Western blot - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Blocking and dilution buffer: 5% NFDM/TBS.
  

  Exposure time: 48 seconds.

  The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID: 26516065).

  Negative control: CTLL-2 (PMID: 1370948) is treated as a negative cell line according to the literature, that CD19 is a B lymphocyte cell-surface marker that is expressed early during pre-B-cell differentiation, not in T cells.

  All lanes: Western blot - Anti-CD19 antibody [EPR23174-145] (ab245235) at 1/1000 dilution

  Lane 1: WEHI-231 (mouse B cell lymphoma B lymphocyte), whole cell lysate at 20 µg

  Lane 2: A20 (mouse reticulum sarcoma B lymphocyte), whole cell lysate at 20 µg

  Lane 3: CTLL-2 (mouse T lymphocyte), whole cell lysate at 20 µg

  Secondary

  All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution

  Predicted band size: 61 kDa

  Observed band size: 60-120 kDa

• 

  Immunoprecipitation - Anti-CD19 antibody [EPR23174-145] (ab245235)

  CD19 was immunoprecipitated from 0.35 mg mouse spleen lysate with ab245235 at 1/30 dilution (2μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab245235 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.
  

  Lane 1: Mouse spleen lysate 10μg

  Lane 2: ab245235 IP in mouse spleen lysate

  Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab245235 in mouse spleen lysate

  Blocking and dilution buffer and concentration: 5% NFDM/TBST.

  Exposure time: 30 seconds.

  All lanes: Immunoprecipitation - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Predicted band size: 61 kDa

  Observed band size: 60-120 kDa

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Immunohistochemical analysis of paraffin-embedded mouse spleen tissue labeling CD19 with ab245235 at 1/1000 dilution (0.446 μg/ml) followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP Polymer). Positive staining on mouse spleen (PMID: 18648532). The section was incubated with ab245235 for 10 mins at room temperature. The immunostaining staining was performed on a Leica Biosystems BOND^® RX instrument. Counterstained with hematoxylin.
  

  Secondary antibody only control: Secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP Polymer).

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.

• 

  Immunocytochemistry/ Immunofluorescence - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized mouse PBMC (mouse primary peripheral blood mononuclear cell) cells labeling CD19 with ab245235 at 1/50 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077 AlexaFluor^®488 Goat anti-Rabbit secondary antibody at 1/1000 dilution (Green). Confocal image showing membranous staining in some subsets of mouse PBMCs. Alexa Fluor® 594 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor^® 594) was used to counterstain tubulin at 1/200 dilution (Red). The nuclear counterstain was DAPI (Blue).
  

  Secondary antibody only control: Secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077 AlexaFluor^®488 Goat anti-Rabbit secondary at 1/1000 dilution.

• 

  Western blot - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Blocking and dilution buffer: 5% NFDM/TBST.
  

  Exposure time: 48 seconds.

  The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID: 26516065).

  All lanes: Western blot - Anti-CD19 antibody [EPR23174-145] (ab245235) at 1/1000 dilution

  All lanes: Mouse spleen tissue lysate at 20 µg

  Secondary

  All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution

  Predicted band size: 61 kDa

  Observed band size: 60-120 kDa

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded mouse colon tissue staining CD68 with Anti-CD68 antibody [EPR23917-164] ab283654 at a 1/100 dilution, ab245235 anti-CD19 used at 1/1000 dilution and Anti-CD3 epsilon antibody [CAL57] ab237721 anti-CD3 used at a 1/2000 dilution. Opal Polymer HRP Ms + Rb was used as a secondary antibody, and DAPI was used for a nuclear counter stain. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.

  Panel A: merged staining of anti-CD68 (magenta; Opal^™520), anti-CD19 (green; Opal^™690) and anti-CD3 (grey; Opal^™570) on mouse colon.
  
  Panel B: anti-CD68 staining macrophages in mouse colon.
  
  Panel C: anti-CD19 staining B lymphocytes in mouse colon.
  
  Panel D: anti-CD3 staining T lymphocytes in mouse colon.
  
  Nuclear DNA was labeled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-CD68 antibody [EPR23917-164] ab283654, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND^®RX instrument with an Opal^™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Immunohistochemical analysis of formalin fixed paraffin embedded mouse spleen labelling CD19 with ab245235 at a concentration of 1µg/ml.

  
  The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a ChromoMap DAB kit and anti-rabbit HQ and anti-HQ HRP detection.
  Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.
  
  ab245235 Anti-CD19 antibody [EPR23174-145] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II.
  Image inset shows absence of staining in secondary antibody only control.
  
  Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual)
• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded mouse spleen treated with lipopolysaccharide (1 ug/ml) for 16 hours and brefeldin a (1 ug/ml) for overnight tissue staining CD80 with Anti-CD80 antibody [EPR28978-182] ab322922 at a 1:2000 (0.257 ug/ml) dilution, ab245235 anti-CD19 used at 1:1000 (0.444 ug/ml) dilution.

  Panel A: merged staining of anti-CD80 (green; Opal™520) and anti-CD19 (magenta; Opal™570) on mouse spleen treated with Lipopolysaccharide.
  
  Panel B: anti-CD80 staining immune cells in mouse spleen treated with Lipopolysaccharide.
  
  Panel C: ant-CD19 staining B lymphocytes in mouse spleen treated with Lipopolysaccharide.
  
  Panel D: Nuclear DNA was labeled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-CD80 antibody [EPR28978-182] ab322922 and ab245235 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Nuclear counter stain with DAPI.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.

• 

  Flow Cytometry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Flow cytometry overlay histogram showing CD3+ve mouse splenocytes stained with ab245235 (right) and with Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control, used at the same concentration and conditions as the primary antibody (left). The cells were incubated in 1x PBS containing 10μg/ml anti CD16/CD32 and 10% normal goat serum to block FC receptors and non-specific protein-protein interaction followed by the antibody (ab245235) (1x 10⁶ in 100μl at 1.0 μg/ml (1/500)) for 30min on ice.

  The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor^® 488) preadsorbed was incubated at 1/4000 for 30min on ice

  Unlabelled sample was also used as a control (this line is not shown for the purpose of simplicity).

  Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded mouse spleen tissue staining CD23 with Anti-CD23 antibody [EPR28712-26] ab315289 at a 1/2000 dilution (0.253 µg/ml), CD19 with ab245235 at 1/1000 dilution (0.444 µg/ml), and CD3 with Anti-CD3 epsilon antibody [CAL57] ab237721 at 1/8000 dilution (0.07 µg/ml), followed by a ready to use secondary antibody Opal Polymer HRP Ms + Rb.

  Panel A: merged staining of anti-CD23 (green; Opal™520), anti-CD19 (magenta; Opal™570) and anti-CD3 (yellow; Opal™690) on mouse spleen.
  Panel B: anti-CD23 staining B lymphocytes in mouse spleen.
  Panel C: anti-CD19 staining B lymphocytes in mouse spleen.
  Panel D: anti-CD3 staining T lymphocytes in mouse spleen.
  Nuclear DNA was labeled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-CD23 antibody [EPR28712-26] ab315289, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded mouse lymph node tissue staining CD23 with Anti-CD23 antibody [EPR28712-26] ab315289 at a 1/2000 dilution (0.253 µg/ml), CD19 with ab245235 at 1/1000 dilution (0.444 µg/ml), and CD3 with Anti-CD3 epsilon antibody [CAL57] ab237721 at 1/8000 dilution (0.07 µg/ml), followed by a ready to use secondary antibody Opal Polymer HRP Ms + Rb.

  Panel A: merged staining of anti-CD23 (green; Opal™520), anti-CD19 (magenta; Opal™570) and anti-CD3 (yellow; Opal™690) on mouse lymph node.
  Panel B: anti-CD23 staining B lymphocytes in mouse lymph node.
  Panel C: anti-CD19 staining B lymphocytes in mouse lymph node.
  Panel D: anti-CD3 staining T lymphocytes in mouse lymph node.
  Nuclear DNA was labeled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-CD23 antibody [EPR28712-26] ab315289, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded mouse thymus tissue staining CD23 with Anti-CD23 antibody [EPR28712-26] ab315289 at a 1/2000 dilution (0.253 µg/ml), CD19 with ab245235 at 1/1000 dilution (0.444 µg/ml), and CD3 with Anti-CD3 epsilon antibody [CAL57] ab237721 at 1/8000 dilution (0.07 µg/ml), followed by a ready to use secondary antibody Opal Polymer HRP Ms + Rb.

  Panel A: merged staining of anti-CD23 (green; Opal™520), anti-CD19 (magenta; Opal™570) and anti-CD3 (yellow; Opal™690) on mouse thymus.
  Panel B: anti-CD23 staining B lymphocytes in mouse thymus.
  Panel C: anti-CD19 staining B lymphocytes in mouse thymus.
  Panel D: anti-CD3 staining T lymphocytes in mouse thymus.
  Nuclear DNA was labeled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-CD23 antibody [EPR28712-26] ab315289, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.

• 

  Flow Cytometry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Flow cytometry staining of C57BL/6 mouse splenocytes with ab245235 (right) or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (left). Cells were incubated for 30 min on ice in 1x PBS containing 10µg/ml anti CD16/CD32 and 10% normal goat serum to block FC receptors and non-specific protein-protein interaction followed by the antibody ab245235 or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (1x 10⁶in 100 µl at 1.0 µg/ml (1/2120)) for 30min on ice. The cells were simultaneously stained with CD3.

  The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min on ice

  Acquisition of >30000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter. Events were gated on live cells.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Mouse bone marrow staining of F4/80 with Anti-F4/80 antibody [EPR26545-166] ab300421 at a 1/5000 (0.1 µg/ml) dilution, CD19 with ab245235 at 1/1000 (0.444 µg/ml) dilution and CD3 with Anti-CD3 epsilon antibody [CAL57] ab237721 at 1/2000 ( 0.264 µg/ml) dilution.

  Panel A: merged staining of anti-F4/80 (magenta; Opal™690), anti-CD19 (green; Opal™520) and anti-CD3 (gray; Opal™570) on mouse bone marrow.
  Panel B: anti-F4/80 staining macrophages in mouse bone marrow.
  Panel C: anti-CD19 staining B lymphocytes in mouse bone marrow.
  Panel D: anti-CD3 staining T lymphocytes in mouse bone marrow.
  Nuclear DNA was labelled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-F4/80 antibody [EPR26545-166] ab300421, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND^® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0 epitope retrieval solution2) for 20 mins.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Mouse thymus staining of NCR1 with Anti-NCR1 antibody [EPR23097-35] ab233558 at a 1/500 (1.062 µg/ml) dilution, CD19 with ab245235 at 1/1000 (0.444 µg/ml) dilution and CD3 with Anti-CD3 epsilon antibody [CAL57] ab237721 at 1/2000 ( 0.264 µg/ml) dilution.

  Panel A: merged staining of anti-NCR1 (magenta; Opal™690), anti-CD19 (green; Opal™520) and anti-CD3 (gray; Opal™570) on mouse thymus.
  Panel B: anti-NCR1 staining natural killer cells in mouse thymus.
  Panel C: anti-CD19 staining B lymphocytes in mouse thymus.
  Panel D: anti-CD3 staining T lymphocytes in mouse thymus.
  Nuclear DNA was labelled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-NCR1 antibody [EPR23097-35] ab233558, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND^® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0 epitope retrieval solution2) for 20 mins.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Mouse lymph node staining of NCR1 with Anti-NCR1 antibody [EPR23097-35] ab233558 at a 1/500 (1.062 µg/ml) dilution, CD19 with ab245235 at 1/1000 (0.444 µg/ml) dilution and CD3 with Anti-CD3 epsilon antibody [CAL57] ab237721 at 1/2000 ( 0.264 µg/ml) dilution.

  Panel A: merged staining of anti-NCR1 (magenta; Opal™690), anti-CD19 (green; Opal™520) and anti-CD3 (gray; Opal™570) on mouse lymph node.
  Panel B: anti-NCR1 staining natural killer cells in mouse lymph node.
  Panel C: anti-CD19 staining B lymphocytes in mouse lymph node..
  Panel D: anti-CD3 staining T lymphocytes in mouse lymph node.
  Nuclear DNA was labelled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-NCR1 antibody [EPR23097-35] ab233558, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND^® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0 epitope retrieval solution2) for 20 mins.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Mouse spleen staining of NCR1 with Anti-NCR1 antibody [EPR23097-35] ab233558 at a 1/500 (1.062 µg/ml) dilution, CD19 with ab245235 at 1/1000 (0.444 µg/ml) dilution and CD3 with Anti-CD3 epsilon antibody [CAL57] ab237721 at 1/2000 ( 0.264 µg/ml) dilution.

  Panel A: merged staining of anti-NCR1 (magenta; Opal™690), anti-CD19 (green; Opal™520) and anti-CD3 (gray; Opal™570) on mouse spleen.
  Panel B: Anti-NCR1 staining natural killer cells in mouse spleen.
  Panel C: anti-CD19 staining B lymphocytes in mouse spleen.
  Panel D: anti-CD3 staining T lymphocytes in mouse spleen.
  Nuclear DNA was labelled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-NCR1 antibody [EPR23097-35] ab233558, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND^® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0 epitope retrieval solution2) for 20 mins.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Mouse spleen staining of F4/80 with Anti-F4/80 antibody [EPR26545-166] ab300421 at a 1/5000 (0.1 µg/ml) dilution, CD19 with ab245235 at 1/1000 (0.444 µg/ml) dilution and CD3 with Anti-CD3 epsilon antibody [CAL57] ab237721 at 1/2000 ( 0.264 µg/ml) dilution.

  Panel A: merged staining of anti-F4/80 (magenta; Opal™690), anti-CD19 (green; Opal™520) and anti-CD3 (gray; Opal™570) on mouse spleen.
  Panel B: anti-F4/80 staining macrophages in mouse spleen.
  Panel C: anti-CD19 staining B lymphocytes in mouse spleen.
  Panel D: anti-CD3 staining T lymphocytes in mouse spleen.
  Nuclear DNA was labelled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-F4/80 antibody [EPR26545-166] ab300421, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND^® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0 epitope retrieval solution2) for 20 mins.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Mouse lymph node staining of F4/80 with Anti-F4/80 antibody [EPR26545-166] ab300421 at a 1/5000 (0.1 µg/ml) dilution, CD19 with ab245235 at 1/1000 (0.444 µg/ml) dilution and CD3 with Anti-CD3 epsilon antibody [CAL57] ab237721 at 1/2000 ( 0.264 µg/ml) dilution.

  Panel A: merged staining of anti-F4/80 (magenta; Opal™690), anti-CD19 (green; Opal™520) and anti-CD3 (gray; Opal™570) on mouse lymph node.
  Panel B: anti-F4/80 staining macrophages in mouse lymph node.
  Panel C: anti-CD19 staining B lymphocytes in mouse lymph node.
  Panel D: anti-CD3 staining T lymphocytes in mouse lymph node.
  Nuclear DNA was labelled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-F4/80 antibody [EPR26545-166] ab300421, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND^® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0 epitope retrieval solution2) for 20 mins.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Mouse thymus staining of F4/80 with Anti-F4/80 antibody [EPR26545-166] ab300421 at a 1/5000 (0.1 µg/ml) dilution, CD19 with ab245235 at 1/1000 (0.444 µg/ml) dilution and CD3 with Anti-CD3 epsilon antibody [CAL57] ab237721 at 1/2000 ( 0.264 µg/ml) dilution.

  Panel A: merged staining of anti-F4/80 (magenta; Opal™690), anti-CD19 (green; Opal™520) and anti-CD3 (gray; Opal™570) on mouse thymus.
  Panel B: anti-F4/80 staining macrophages in mouse thymus.
  Panel C: anti-CD19 staining B lymphocytes in mouse thymus.
  Panel D: anti-CD3 staining T lymphocytes in mouse thymus.
  Nuclear DNA was labelled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-F4/80 antibody [EPR26545-166] ab300421, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND^® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0 epitope retrieval solution2) for 20 mins.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Mouse spleen tissue staining Neutrophil Elastase with Anti-Neutrophil Elastase antibody [EPR28386-66] ab310335 at a 1/500 ( 1.076 µg/ml) dilution, CD19 with ab245235 at a 1/1000 ( 0.444 µg/ml) dilution and CD3 with Anti-CD3 epsilon antibody [CAL57] ab237721 at a 1/2000 ( 0.264 µg/ml) dilution followed by a ready to use secondary antibody Opal Polymer HRP Ms + Rb.

  Panel A: merged staining of anti-Neutrophil Elastase (magenta; Opal™690), anti-CD19 (green; Opal™520) and anti-CD3 (gray; Opal™690) on mouse spleen.Panel B: anti-Neutrophil Elastase staining neutrophils in mouse spleen.
  Panel C: anti-CD19 staining B lymphocytes in mouse spleen.
  Panel D: anti-CD3 staining T lymphocytes in mouse spleen.
  Nuclear DNA was labeled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-Neutrophil Elastase antibody [EPR28386-66] ab310335, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND^® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Mouse thymus tissue staining Neutrophil Elastase with Anti-Neutrophil Elastase antibody [EPR28386-66] ab310335 at a 1/500 ( 1.076 µg/ml) dilution, CD19 with ab245235 at a 1/1000 ( 0.444 µg/ml) dilution and CD3 with Anti-CD3 epsilon antibody [CAL57] ab237721 at a 1/2000 ( 0.264 µg/ml) dilution followed by a ready to use secondary antibody Opal Polymer HRP Ms + Rb.

  Panel A: merged staining of anti-Neutrophil Elastase (magenta; Opal™690), anti-CD19 (green; Opal™520) and anti-CD3 (gray; Opal™690) on mouse spleen.Panel B: anti-Neutrophil Elastase staining neutrophils in mouse spleen.
  Panel C: anti-CD19 staining B lymphocytes in mouse spleen.
  Panel D: anti-CD3 staining T lymphocytes in mouse spleen.
  Nuclear DNA was labeled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-Neutrophil Elastase antibody [EPR28386-66] ab310335, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND^® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Mouse bone marrow tissue staining Neutrophil Elastase with Anti-Neutrophil Elastase antibody [EPR28386-66] ab310335 at a 1/500 ( 1.076 µg/ml) dilution, CD19 with ab245235 at a 1/1000 ( 0.444 µg/ml) dilution and CD3 with Anti-CD3 epsilon antibody [CAL57] ab237721 at a 1/2000 ( 0.264 µg/ml) dilution followed by a ready to use secondary antibody Opal Polymer HRP Ms + Rb.

  Panel A: merged staining of anti-Neutrophil Elastase (magenta; Opal™690), anti-CD19 (green; Opal™520) and anti-CD3 (gray; Opal™690) on mouse spleen.Panel B: anti-Neutrophil Elastase staining neutrophils in mouse spleen.
  Panel C: anti-CD19 staining B lymphocytes in mouse spleen.
  Panel D: anti-CD3 staining T lymphocytes in mouse spleen.
  Nuclear DNA was labeled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-Neutrophil Elastase antibody [EPR28386-66] ab310335, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND^® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded Mouse lymph node tissue staining Neutrophil Elastase with Anti-Neutrophil Elastase antibody [EPR28386-66] ab310335 at a 1/500 ( 1.076 µg/ml) dilution, CD19 with ab245235 at a 1/1000 ( 0.444 µg/ml) dilution and CD3 with Anti-CD3 epsilon antibody [CAL57] ab237721 at a 1/2000 ( 0.264 µg/ml) dilution followed by a ready to use secondary antibody Opal Polymer HRP Ms + Rb.

  Panel A: merged staining of anti-Neutrophil Elastase (magenta; Opal™690), anti-CD19 (green; Opal™520) and anti-CD3 (gray; Opal™690) on mouse spleen.Panel B: anti-Neutrophil Elastase staining neutrophils in mouse spleen.
  Panel C: anti-CD19 staining B lymphocytes in mouse spleen.
  Panel D: anti-CD3 staining T lymphocytes in mouse spleen.
  Nuclear DNA was labeled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-Neutrophil Elastase antibody [EPR28386-66] ab310335, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND^® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins

• 

  This image is courtesy of an anonymous customer review

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Immunohistochemistry analysis (Formalin/PFA-fixed paraffin-embedded sections) of paraformaldehyde fixed mouse spleen tissue. Stained with ab245235 at 1/1000 dilution. Secondary antibody used was Dako EnVision+ System- HRP Labelled Polymer Anti-R. Blocking was done with 5% serum for 1 hour at 21°C. The sample was incubated with the primary antibody and 5% Normal Goat Serum for 19 hours at 4°C. Antigen retrieval method was heat mediated Tris/EDTA pH 9.0.

• 

  This image is courtesy of an anonymous customer review

  Immunohistochemistry (Frozen sections) - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Immunohistochemistry (Frozen sections) analysis of acetone-fixed mouse spleen tissue staining with ab245235 at 1/1000 dilution. Secondary antibody was Dako EnVision+ System- HRP Labelled Polymer Anti-R Samples were incubated with the primary antibody with 5% Normal Goat Serum for 19 hours at 4°C. Blocking was done using 5% serum for 1 hour at 21°C

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  CD19 Multiplex immunohistochemistry staining of Mouse spleen using rabbit Anti-CD19 antibody

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded mouse spleen tissue staining CD21+CD35 with Anti-CD21+CD35 antibody [RM2062] ab318999 at a 1:2000 (0.255 ug/ml) dilution, ab245235 anti-CD19 used at 1:1000 (0.444 ug/ml) dilution and Anti-CD3 epsilon antibody [SP7] ab16669 anti-CD3 used at a 1:150 (0.06 ug/ml) dilution.

  Panel A: merged staining of anti-CD21+CD35 (green; Opal™520), anti-CD19 (magenta; Opal™690) and anti-CD3 (yellow; Opal™570) on mouse spleen.
  
  Panel B: anti-CD21+CD35 staining B lymphocytes in mouse spleen.
  
  Panel C: anti-CD19 staining B lymphocytes in mouse spleen.
  
  Panel D: anti-CD3 staining T lymphocytes in mouse spleen.
  
  Nuclear DNA was labeled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-CD21+CD35 antibody [RM2062] ab318999, ab245235 and Anti-CD3 epsilon antibody [SP7] ab16669 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Nuclear counter stain with DAPI.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded mouse spleen tissue staining LY6C with Anti-LY6C antibody [RM1151] ab317272 at a 1:100 (0.978 ug/ml) dilution, Anti-CD11b antibody [EPR1344] ab133357 anti-CD11b used at 1:20000 (0.05 ug/ml) dilution and ab245235 anti-CD19 used at a 1:1000 (0.999 ug/ml) dilution.

  Panel A: merged staining of anti-Ly6c (green; Opal™690), anti-CD11b (magenta; Opal™570) and anti-CD19 (yellow; Opal™520) on mouse spleen.
  
  Panel B: anti-Ly6c stained on monocytes/macrophages.
  
  Panel C: anti-CD11b stained on monocytes/macrophages.
  
  Panel D: anti-CD19 stained on B cells.
  
  Co-staining of Ly6c and CD11b can be observed.
  
  The section was incubated in three rounds of staining: in the order of Anti-LY6C antibody [RM1151] ab317272, Anti-CD11b antibody [EPR1344] ab133357, and ab245235 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.
  
  Nuclear DNA was labeled with DAPI (shown in blue).

  The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Nuclear counter stain with DAPI.

  Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  CD19 Multiplex immunohistochemistry staining of Mouse spleen using rabbit Anti-CD19 antibody

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded mouse spleen tissue staining CD272/BTLA with Anti-CD272/BTLA antibody [EPR29068-115] ab317827 at a 1:1000 (0.44 ug/ml) dilution, Anti-CD272/BTLA antibody [EPR29068-115] ab317827 anti-BTLA used at 1:100 (4.92 ug/ml) dilution and Anti-CD3 epsilon antibody [SP7] ab16669 anti-CD3 used at a 1:150 (0.06 ug/ml) dilution.

  Panel A: merged staining of anti-CD19 (magenta; Opal™690), anti-BTLA (green; Opal™520) and anti-CD3 (yellow; Opal™570) on mouse spleen.
  
  Panel B: anti-CD19 staining B lymphocytes in mouse spleen.
  
  Panel C: anti-BTLA staining B lymphocytes and T lymphocytes in mouse spleen.
  
  Panel D: anti-CD3 staining T lymphocytes in mouse spleen.
  
  Nuclear DNA was labeled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of ab245235, Anti-CD272/BTLA antibody [EPR29068-115] ab317827 and Anti-CD3 epsilon antibody [SP7] ab16669 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Nuclear counter stain with DAPI.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  CD19 Multiplex immunohistochemistry staining of mouse liver tissue using rabbit Anti-CD19 antibody

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded mouse liver tissue staining MARCO with Anti-MARCO antibody [RM1219] ab323717 at a 1:200 (2.49 ug/ml) dilution, ab245235 anti-CD19 used at 1:1000 (0.22 ug/ml) dilution and Anti-CD3 epsilon antibody [CAL57] ab237721 anti-CD3 used at a 1:2000 (0.26 ug/ml) dilution.

  Panel A: merged staining of anti-MARCO (green; Opal™520), anti-CD19 (gray; Opal™690) and anti-CD3 (magenta; Opal™570) on mouse liver.
  
  Panel B: anti-MARCO staining macrophages in mouse liver.
  
  Panel C: ant-CD19 staining B lymphocytes in mouse liver.
  
  Panel D: ant-CD3 staining T lymphocytes in mouse liver.
  
  Nuclear DNA was labeled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-MARCO antibody [RM1219] ab323717, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Nuclear counter stain with DAPI.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  CD19 Multiplex immunohistochemistry staining of mouse lung tissue using rabbit Anti-CD19 antibody

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded mouse lung tissue staining MARCO with Anti-MARCO antibody [RM1219] ab323717 at a 1:200 (2.49 ug/ml) dilution, ab245235 anti-CD19 used at 1:1000 (0.22 ug/ml) dilution and Anti-CD3 epsilon antibody [CAL57] ab237721 anti-CD3 used at a 1:2000 (0.26 ug/ml) dilution.

  Panel A: merged staining of anti-MARCO (green; Opal™520), anti-CD19 (gray; Opal™690) and anti-CD3 (magenta; Opal™570) on mouse lung.
  
  Panel B: anti-MARCO staining macrophages in mouse lung.
  
  Panel C: ant-CD19 staining B lymphocytes in mouse lung.
  
  Panel D: ant-CD3 staining T lymphocytes in mouse lung.
  
  Nuclear DNA was labeled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-MARCO antibody [RM1219] ab323717, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Nuclear counter stain with DAPI.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  CD19 Multiplex immunohistochemistry staining of mouse spleen tissue using rabbit Anti-CD19 antibody

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded mouse spleen tissue staining MARCO with Anti-MARCO antibody [RM1219] ab323717 at a 1:200 (2.49 ug/ml) dilution, ab245235 anti-CD19 used at 1:1000 (0.22 ug/ml) dilution and Anti-CD3 epsilon antibody [CAL57] ab237721 anti-CD3 used at a 1:2000 (0.26 ug/ml) dilution.

  Panel A: merged staining of anti-MARCO (green; Opal™520), anti-CD19 (gray; Opal™690) and anti-CD3 (magenta; Opal™570) on mouse spleen.
  
  Panel B: anti-MARCO staining macrophages in mouse spleen.
  
  Panel C: ant-CD19 staining B lymphocytes in mouse spleen.
  
  Panel D: ant-CD3 staining T lymphocytes in mouse spleen.
  
  Nuclear DNA was labeled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-MARCO antibody [RM1219] ab323717, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  Nuclear counter stain with DAPI.

  Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.

• 

  Multiplex immunohistochemistry - Anti-CD19 antibody [EPR23174-145] (ab245235)

  Multiplex immunohistochemistry analysis of formalin/PFA-fixed paraffin-embedded mouse small intestine tissue staining CD68 with Anti-CD68 antibody [EPR23917-164] ab283654 at a 1/100 dilution, ab245235 anti-CD19 used at 1/1000 dilution and Anti-CD3 epsilon antibody [CAL57] ab237721 anti-CD3 used at a 1/2000 dilution. Opal Polymer HRP Ms + Rb was used as a secondary antibody, and DAPI was used for a nuclear counter stain. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins.

  Panel A: merged staining of anti-CD68 (magenta; Opal^™520), anti-CD19 (green; Opal^™690) and anti-CD3 (grey; Opal^™570) on mouse small intestine.
  
  Panel B: anti-CD68 staining macrophages in mouse small intestine.
  
  Panel C: anti-CD19 staining B lymphocytes in mouse small intestine.
  
  Panel D: anti-CD3 staining T lymphocytes in mouse small intestine.
  
  Nuclear DNA was labeled with DAPI (shown in blue).

  The section was incubated in three rounds of staining: in the order of Anti-CD68 antibody [EPR23917-164] ab283654, ab245235 and Anti-CD3 epsilon antibody [CAL57] ab237721 for 30 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

  The immunostaining was performed on a Leica Biosystems BOND^®RX instrument with an Opal^™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.